3Goldmark E, Niver B, Ginsberg D A. Neurogenic bladder: from diagnosis to management[J]. Curr Urol Rep, 2014, 15(10): 448.
4Liao L, Zhang F, Chen G. Midterm outcomes of protection for upper urinary tract function by augmentation enterocystoplasty in patients with neurogenic bladder[J]. Int Urol Nephrol, 2014, 46(11): 2117-2125.
5Stohrer M, Blok B, Castro-Diaz D, et al. EAU guidelines on neurogenic lower urinary tract dysfunction[J]. Eur Urol, 2009, 56(1): 81-88.
7Wyndaele J J. Self-intermittent catheterization in multiple sclerosis[J]. Ann Phys Rehabil Med, 2014, 57(5): 315-320.
8Danforth T L, Ginsberg D A. Neurogenic lower urinary tract dysfunction: how, when, and with which patients do we use urodynamics?[J]. Urol Clin North Am, 2014, 41(3): 445-452, ix.
9Game X, Chartier-Kastler E, Ayoub N, et al. Outcome after treatment of detrusor sphincter dyssynergia by temporary stent[J]. Spinal Cord, 2008, 46(1): 74-77.
10Kutzenberger J, Domurath B, Sauerwein D. Spastic bladder and spinal cord injury: seventeen years of experience with sacral deafferentation and implantation of an anterior root stimulator[J]. Artif Organs, 2005, 29(3): 239-241.
3Zi-Fa Wang and Chang Liu Pittsburgh, USA Department ot Surgery, University of Pittsburgh Me- dical Center, Pittsburgh, PA 15213, USA,Division of Hepa- tobiliary Surgery . First Hospital, Xi’ an Jiaotong University , Xi’ an 710061, China.Liver retransplantation: indications and outcomes[J].Hepatobiliary & Pancreatic Diseases International,2004,3(2):175-178. 被引量：4
